Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

NYC Biotech Gets Investment Boost

by Rick Mullin
August 4, 2014 | A version of this story appeared in Volume 92, Issue 31

[+]Enlarge
Credit: Michael McCoy/C&EN
The Alexandria Center on Manhattan’s East Side.
Photo of the Alexandria Center for Life Science in New York City.
Credit: Michael McCoy/C&EN
The Alexandria Center on Manhattan’s East Side.

The investment arms of Pfizer, Eli Lilly & Co., and Johnson & Johnson are among contributors to a $51 million fund raised by Seattle-based Accelerator Corp., which plans to use it to nurture emerging biotech firms in New York City. Accelerator will be based at the Alexandria Center for Life Science, located in the city’s East Side Medical Corridor. Pfizer and Lilly have operations at the Alexandria Center, as does Roche. However, the nascent research hub has been less successful in attracting the smaller firms common in other biotech centers. Accelerator says it has nurtured a dozen early-stage biotech firms in Seattle and seeks to replicate that effort in New York.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.